Compare EVAX & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVAX | LIQT |
|---|---|---|
| Founded | 2008 | 2004 |
| Country | Denmark | Denmark |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.4M | 28.8M |
| IPO Year | 2020 | 2011 |
| Metric | EVAX | LIQT |
|---|---|---|
| Price | $3.13 | $0.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $11.67 | $4.30 |
| AVG Volume (30 Days) | 28.5K | ★ 359.9K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $42.12 |
| Revenue Next Year | $328.20 | $63.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.28 | $0.74 |
| 52 Week High | $12.15 | $3.35 |
| Indicator | EVAX | LIQT |
|---|---|---|
| Relative Strength Index (RSI) | 39.30 | 33.51 |
| Support Level | $2.92 | $0.74 |
| Resistance Level | $3.62 | $1.00 |
| Average True Range (ATR) | 0.29 | 0.10 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 21.91 | 39.62 |
Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is renowned in three business areas: ceramic membranes and membrane incorporated liquid filtration systems, ceramic diesel particulate filters (DPFs) to control soot exhaust particles and black carbon emission from diesel engines, and plastic components for usage across various industries. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, Hybrid Technology Membranes and others. The Company operates through three reportable segments: Systems and Aftermarket, Filters and Membranes, and Components.